THC vs UHS
Tenet Healthcare Corp. and Universal Health Services, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | THC | UHS |
|---|---|---|
| Revenue | $21.3B | $17.4B |
| Net income | $2.4B | $1.5B |
| Gross margin | — | — |
| Net margin | 11.1% | 8.6% |
| Return on equity | 56.4% | 21.4% |
| Diluted EPS | $15.49 | — |
| Dividend / share | — | $0.80 |
| Payout ratio | — | 3.4% |
| Free cash flow | $2.5B | $849.2M |
| Equity | $4.2B | $7.3B |
| Net debt / equity | 2.42× | 0.63× |
| Current ratio | 1.76× | 1.05× |
| Revenue CAGR 5y | 3.9% | 8.5% |
| Profit CAGR 5y | 25.2% | 9.5% |
THC bills 1.2× the revenue of UHS, and keeps more of each dollar of revenue as profit (11.1% against 8.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | THC | UHS |
|---|---|---|
| FY2025 | $21.3B | $17.4B |
| FY2024 | $20.7B | $15.8B |
| FY2023 | $20.6B | $14.3B |
| FY2022 | $19.2B | $13.4B |
| FY2021 | $19.5B | $12.6B |
| FY2020 | $17.6B | $11.6B |
| FY2019 | $18.5B | $11.4B |
| FY2018 | $18.3B | $10.8B |
| FY2017 | $20.6B | $10.4B |
| FY2016 | $21.1B | $9.8B |
Net income by year
Bottom line
| Fiscal year | THC | UHS |
|---|---|---|
| FY2025 | $2.4B | $1.5B |
| FY2024 | $4.1B | $1.1B |
| FY2023 | $1.3B | $717.8M |
| FY2022 | $1.0B | $675.6M |
| FY2021 | $1.5B | $991.6M |
| FY2020 | $768.0M | $944.0M |
| FY2019 | $171.0M | $814.9M |
| FY2018 | $459.0M | $779.7M |
| FY2017 | $-320.0M | $752.3M |
| FY2016 | $176.0M | $702.4M |
Advertisement
AdSense · Rectangle 336×280